Solarworld Energy IPO Day 3: Check GMP, Subscription Status & Key Highlights
The ₹490 crore initial public offering (IPO) of Solarworld Energy Solutions entered its final day of subscription today, with the issue subscribed 3.99 times by the end of Day 2.
Solarworld Energy IPO: Issue Details
- Issue Size: Solarworld Energy IPO is a book-building issue of ₹490 crores, comprising a fresh issue of ₹440 crores and an offer for sale of ₹50 crores.
- Price Band: The price band is set between ₹333 and ₹351 per share.
- Book-running lead managers: Nuvama Wealth Management Limited and SBI Capital Markets Limited
- Registrar: MUFG Intime India Private Limited
- Listing: The shares are proposed to be listed on the NSE and the BSE on September 30.
Solarworld Energy IPO Day 3: Subscription Details
[25-September-2025 10:51:00]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.02 |
|
Non-Institutional Investors |
10.13 |
|
Retail Individual Investors (RIIs) |
18.72 |
|
Total |
6.18 |
Utilisation of IPO Proceeds
The company aims to use the net proceeds from the fresh issue towards the following objectives.
- Invest in Kartik Solarworld Private Limited (Solarworld Energy’s subsidiary) for financing the establishment of a 1.2 GW solar PV TopCon Cell manufacturing facility in MP
- General corporate purposes
Solarworld Energy IPO GMP Details
As of 25 September 2025, Solarworld Energy IPO's GMP stood at ₹53. The estimated listing price is ₹404, i.e., a 15.10% gain per share over the upper price band.
Source: Business Standard Report dated 25 September 2025
|
Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.